Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
A randomized trial of human C1 inhibitor prophylaxis in children with hereditary angioedema.
Journal: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
Published: November 12, 2018
EXHANCE-12: 1-year study of the exhalation delivery system with fluticasone (EDS-FLU) in chronic rhinosinusitis.
Journal: International forum of allergy & rhinology
Published: February 03, 2018
Preventing Hereditary Angioedema Attacks in Children Using Cinryze®: Interim Efficacy and Safety Phase 3 Findings.
Journal: International archives of allergy and immunology
Published: December 08, 2016
Safety and efficacy of C1 esterase inhibitor for acute attacks in children with hereditary angioedema.
Journal: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
Published: July 06, 2015
Repeat treatment of acute hereditary angioedema attacks with open-label icatibant in the FAST-1 trial.
Journal: Clinical and experimental immunology
Published: March 15, 2014
Escalating doses of C1 esterase inhibitor (CINRYZE) for prophylaxis in patients with hereditary angioedema.
Journal: The journal of allergy and clinical immunology. In practice
Published: June 27, 2013
C1-inhibitor therapy for hereditary angioedema attacks: prospective patient assessments of health-related quality of life.
Journal: Allergy and asthma proceedings
Published: October 03, 2012
Treatment response after repeated administration of C1 esterase inhibitor for successive acute hereditary angioedema attacks.
Journal: Allergy and asthma proceedings
Published: August 04, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026